A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer

By Han Ji-Youn   Lee Dae   Lee Sung   Park Chun   Kim Hae   Kim Eun-A   Yoon Sung   Lee Hong   Lee Jin  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 281-290

Humana Press, Inc

Access to resources Recommend Favorite

Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer

By Umemura Shigeki   Segawa Yoshihiko   Ueoka Hiroshi   Hotta Katsuyuki   Kiura Katsuyuki   Takigawa Nagio   Tabata Masahiro   Bessho Akihiro   Shinkai Tetsu   Tanimoto Mitsune  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 8, 2007-08 ,pp. : 519-524

Springer Publishing Company

Access to resources Recommend Favorite

Modified one-day etoposide and cisplatin combination for previously untreated extensive-disease small-cell lung cancer: A retrospective evaluation of 36 cases

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 914-918

Science Publishers

Access to resources Recommend Favorite

Gemictabine plus carboplatin in patients with advanced non-small cell lung cancer

By Park Se   Jeong Seong   Kyung Sun   Lim Young-Hee   An Chang   Lee Sang   Park Jeong   Bang Soo   Cho Eun   Shin Dong   Lee Jae  

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 359-366

Humana Press, Inc

Access to resources Recommend Favorite

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer

By Oka M.   Fukuda M.   Kuba M.   Ichiki M.   Rikimaru T.   Soda H.   Tsurutani J.   Nakamura Y.   Kawabata S.   Nakatomi K.   Narasaki F.   Nagashima S.   Takatani H.   Fukuda M.   Kinoshita A.   Kohno S.  

European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. : 1998-2004

Elsevier

Access to resources Recommend Favorite